Related Experiment Video
Updated: Oct 17, 2025

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
Published on: May 5, 2020
[Prostatic Urethral Lift under local anesthesia: Single-centre retrospective observational study]
L Dupitout1, F Bladou1, J-C Bernhard1
1Service d'urologie, transplantation rénale et andrologie, CHU de Bordeaux, place Amélie Rabat Leon, 33000 Bordeaux, France.
The UroLift implant procedure can be safely performed using local anesthesia, offering a minimally invasive option for benign prostatic hyperplasia (BPH) symptom relief. This approach enhances patient recovery and preserves sexual function, demonstrating feasibility and effectiveness.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Anesthesiology
Background:
- UroLift implant placement offers advantages over conventional endoscopic surgery, particularly for patients prioritizing sexual function preservation and rapid recovery.
- The absence of general anesthesia contributes to the minimally invasive nature and faster recovery associated with the UroLift procedure.
Purpose of the Study:
- To evaluate the feasibility and outcomes of UroLift implant placement performed under local anesthesia.
- To assess patient tolerance and procedural success rates when using local anesthesia for UroLift.
Main Methods:
- A retrospective analysis of patients undergoing UroLift between 2017 and 2021.
- Local anesthesia protocol involved intraurethral instillation of 2% Xylocaine gel prior to the procedure.
- Primary endpoint: successful procedure completion without additional anesthesia or analgesia due to pain.
Main Results:
- Twenty-seven patients were included (median age 65 years, prostate volume 46mL, baseline IPSS 23).
- The UroLift procedure was successfully completed under local anesthesia in all cases after the initial three patients, with no need for additional anesthesia or analgesia.
- Operating time averaged 10 minutes with minimal pain (VAS 1). At 3 months, International Prostate Symptom Score (IPSS) significantly improved to 9 (P=0.001).
Conclusions:
- UroLift implant placement is feasible and safe under local anesthesia, with no procedural failures.
- The observed improvement in IPSS scores is consistent with findings from previous clinical trials, supporting local anesthesia as a viable option.
Related Concept Videos
Urodynamic Studies: Uroflowmetry
Urologic Endoscopic Procedure: Cystoscopic Examination
Urinary Tract Calculi VI: Surgical Management

